ATTO
Attovia Therapeutics, Inc.
Stock Price & Insider Activity
Historical close with open-market insider transaction markers
Insider activity
Sign in to download CSVBought$52.4M8 buy days
Sold$4.5M2 sell days
Net insider flow+$47.9Mnet buying · 10 years
Latest trade2026-08-06Redmile Group, LLC
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-08-06 | Buy | Redmile Group, LLC | 10% owner | 600,000 | $17.00 | $10.2M | 2 |
| 2026-08-06 | Buy | FHMLS XI, L.P. | 10% owner | 588,235 | $17.00 | $10.0M | 1 |
| 2026-08-06 | Buy | WALSH COLIN | Director | 500,000 | $17.00 | $8.5M | 1 |
| 2026-08-06 | Buy | GOLDMAN SACHS & CO. LLC | Other | 500,000 | $17.00 | $8.5M | 1 |
| 2026-08-06 | Buy | venBio Global Strategic Fund IV, L.P. | 10% owner | 382,352 | $17.00 | $6.5M | 1 |
| 2026-08-06 | Buy | Sanofi | 10% owner | 300,000 | $17.00 | $5.1M | 1 |
| 2026-08-05 | Sell | WALSH COLIN | Director | 105,607 | $21.28 | $2.2M | 22 |
| 2026-08-05 | Sell | GOLDMAN SACHS & CO. LLC | Other | 105,607 | $21.28 | $2.2M | 22 |
| 2026-08-05 | Buy | WALSH COLIN | Director | 85,000 | $21.00 | $1.8M | 1 |
| 2026-08-05 | Buy | GOLDMAN SACHS & CO. LLC | Other | 85,000 | $21.00 | $1.8M | 1 |